Raub Brock Capital Management’s Amgen AMGN Stock Holding History

Raub Brock Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-99,457	Closed	-$18.9M	–	56
2019 Q1	$18.9M	Buy	99,457 +2,802	+3%	+$535K	3.97%	19
2018 Q4	$18.8M	Buy	96,655 +2,195	+2%	+$428K	4.64%	7
2018 Q3	$19.6M	Sell	94,460 -503	-0.5%	-$99.1K	4.33%	11
2018 Q2	$17.5M	Buy	94,963 +3,962	+4%	+$701K	4.14%	14
2018 Q1	$15.5M	Buy	91,001 +1,238	+1%	+$227K	3.86%	17
2017 Q4	$15.6M	Sell	89,763 -2,194	-2%	-$388K	3.87%	15
2017 Q3	$17.1M	Buy	91,957 +5,612	+6%	+$994K	4.4%	10
2017 Q2	$14.9M	Buy	86,345 +8,622	+11%	+$1.4M	4.14%	11
2017 Q1	$12.8M	Buy	77,723 +6,689	+9%	+$1.11M	3.73%	16
2016 Q4	$10.4M	Sell	71,034 -4,583	-6%	-$690K	3.19%	17
2016 Q3	$12.6M	Buy	+75,617	New	+$12.8M	3.93%	11

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raub Brock Capital Management's AMGN Position: Q2 2019 in Review

Raub Brock Capital Management sold out of Amgen (AMGN) in Q2 2019, closing a stake of 99,457 shares — an estimated $18.9M sold.

Raub Brock Capital Management first reported a position in AMGN in Q3 2016 and held it in 11 quarters. The position peaked at $19.6M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Raub Brock Capital Management reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Raub Brock Capital Management sold 99,457 Amgen shares in Q2 2019, an estimated $18.9M.
Raub Brock Capital Management first reported a position in Amgen in Q3 2016 and held it in 11 quarters.
Raub Brock Capital Management's Amgen position peaked at $19.6M in Q3 2018.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Raub Brock Capital Management's 13F filing for Q2 2019, filed 23 Jul 2019.